Kyle Bass Challenges Pharma Companies’ Patents

According to report published on Biocentury.com, the board of Patent Trial and Appeal instituted the inter partes review (IPR) petition. The petition from Coalition for Affordable Drugs led by Kyle Bass challenged a patent that covered various sclerosis drug, Tecfidera dimethyl fumarate from the Biogen Inc. IPR is simply a procedure used to challenge the […]